Cannabis, CBD industry wary of looming decision on epilepsy drug

The most disruptive product to hit the newly legal hemp industry might be one that will never be sold directly to consumers. GW Pharmaceuticals, a London-based biotech company, is awaiting a final decision from the U.S. Food and Drug Administration to produce the first cannabis-derived treatment to win approval as legal medicine. The decision on … Continue reading Cannabis, CBD industry wary of looming decision on epilepsy drug